Who can prescribe Wellbutrin? NP vs MD

If you’re struggling with Binge Eating Disorder (BED), you might be wondering whether you can access treatment through telehealth—especially medications that could help reduce binge episodes and support your recovery. The short answer is yes, and it’s more accessible than you might think.

With telehealth laws now firmly established across the United States, getting evaluated and prescribed medications for BED through virtual appointments is not only legal but increasingly common. This guide breaks down everything you need to know about accessing BED treatment online, which medications are available, what regulations apply in your state, and how to ensure you’re receiving safe, quality care.

Understanding Binge Eating Disorder and Treatment Options

Binge Eating Disorder is the most common eating disorder in the United States, affecting millions of adults. It’s characterized by recurring episodes of eating large amounts of food in a short period (typically within two hours), feeling a loss of control during these episodes, and experiencing significant distress about the behavior—without the purging behaviors seen in bulimia.

To meet diagnostic criteria, these episodes must occur at least once weekly for three months. Unlike other eating disorders, BED isn’t primarily about weight or body image concerns, though those often coexist. The disorder creates a genuine medical and psychological burden that deserves comprehensive treatment.

Treatment for BED typically involves a combination of approaches:

• Psychotherapy (particularly Cognitive Behavioral Therapy and Dialectical Behavior Therapy)
• Nutritional counseling to rebuild healthy eating patterns
• Medication to help reduce binge frequency and address underlying factors
• Support groups and peer connection

While medication alone isn’t a complete solution, it can be an effective component of treatment—and that’s where telehealth access becomes particularly valuable.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Medications Commonly Prescribed for Binge Eating Disorder via Telehealth

Topamax (Topiramate)

Topiramate is an anticonvulsant medication FDA-approved for seizures and migraine prevention. For BED, it’s used off-label based on clinical research showing it can help reduce binge frequency and support impulse control.

How it works for BED: Topiramate appears to affect neurotransmitter systems involved in appetite regulation and impulse control. Many patients report reduced food cravings and fewer binge urges.

Typical approach: Providers usually start with a low dose (25mg) and gradually increase over weeks to minimize side effects. Treatment doses for BED often range from 50–200mg daily.

Important considerations:

• Pregnancy risk: Topiramate is linked to birth defects, including cleft palate. If you’re of childbearing potential, your provider will discuss contraception requirements
• Cognitive effects: Some people experience word-finding difficulties or ‘brain fog,’ especially at higher doses
• Gradual discontinuation: Don’t stop suddenly—tapering is necessary to prevent seizures

Wellbutrin (Bupropion)

Bupropion is FDA-approved for depression and smoking cessation. It’s used off-label for BED based on studies showing it can help reduce binge eating episodes in some patients.

How it works for BED: As a norepinephrine-dopamine reuptake inhibitor (NDRI), bupropion may help by improving mood regulation and reducing the reward-seeking behavior associated with binge eating.

Typical approach: Starting doses are usually 150mg daily, potentially increasing to 300–450mg depending on response and tolerability.

Critical safety information:

• Contraindicated in eating disorders with purging: If you have a history of bulimia or anorexia nervosa, bupropion is not safe due to significantly increased seizure risk
• Seizure risk factors: Also avoid if you have epilepsy, are withdrawing from alcohol or benzodiazepines, or have other seizure risk factors
• Black box warning: Like all antidepressants, carries a warning about increased suicidal thoughts in people under 25—close monitoring is essential
• Avoid alcohol: Alcohol consumption increases seizure risk when taking bupropion

What About Vyvanse?

You may have heard that Vyvanse (lisdexamfetamine) is the only FDA-approved medication specifically for BED. That’s true—but there’s a catch for telehealth access.

Vyvanse is a Schedule II controlled substance (a stimulant medication). While federal telehealth flexibilities currently allow controlled substance prescribing through December 31, 2026, most reputable telehealth platforms are cautious about prescribing stimulants for BED due to abuse potential and stricter oversight. Many states have additional restrictions on controlled substance telehealth prescribing.

As a result, legitimate telehealth services typically focus on non-controlled medication options like topiramate and bupropion, referring patients who might benefit from Vyvanse to in-person specialists. This is actually a sign of responsible prescribing—be wary of any service too quick to prescribe controlled substances online.

Federal Telehealth Regulations: What You Need to Know

The Ryan Haight Act and What It Means for BED Medications

The Ryan Haight Act (2008) is a federal law requiring an in-person medical evaluation before prescribing controlled substances via telemedicine. This law specifically targets drugs with abuse potential—opioids, stimulants, benzodiazepines, and similar medications.

Here’s the crucial point: The Ryan Haight Act does NOT apply to non-controlled medications like Topamax or Wellbutrin. These medications were never subject to federal in-person requirements for telehealth prescribing.

COVID-19 Flexibilities and Current Status (2025–2026)

During the COVID-19 Public Health Emergency, the DEA created temporary exceptions to allow controlled substance prescribing via telehealth without the usual in-person requirement. These flexibilities have been extended multiple times and currently remain in effect through December 31, 2026.

For patients seeking BED treatment with non-controlled medications, this is important background context, but it doesn’t directly affect your access—those medications have always been available via telehealth under federal law.

What this means for you: At the federal level, there are no barriers to receiving prescriptions for Topamax or Wellbutrin via telehealth. Your provider just needs to be licensed in your state and conduct an appropriate evaluation.

State-by-State Telehealth Rules: Do You Need an In-Person Visit?

While federal law permits telehealth prescribing of non-controlled medications, each state has its own medical board regulations that may add requirements. Let’s break down what’s required in key states:

States with NO In-Person Requirement

California: Leads the nation in telehealth flexibility. The state explicitly allows prescribing based on telehealth evaluations—even asynchronous (questionnaire-based) consultations—as long as the standard of care is met. Legislation in 2025 further clarified that a ‘good faith exam’ includes various forms of telehealth.

New York: No in-person requirement for non-controlled medications. (Note: NY implemented an in-person rule in May 2025 for controlled substances, but this doesn’t affect BED medications we’re discussing.)

Texas: Permits telehealth prescribing for non-controlled medications without an in-person visit. Texas has specific restrictions on certain Schedule II drugs, but not for medications like topiramate or bupropion.

Florida: No in-person visit required for non-controlled prescriptions. Florida’s telehealth law primarily restricts certain controlled substances.

Delaware: Full telehealth prescribing allowed. Delaware actually enhanced its telehealth laws in July 2025, clarifying that medication-assisted treatment for opioid use disorder can be initiated via telemedicine.

South Carolina: No explicit in-person requirement. State regulations require an ‘appropriate evaluation,’ which can be conducted via telemedicine as long as it meets the same standard as in-person care.

Michigan and Wisconsin: Both allow telehealth prescribing without mandated in-person visits for non-controlled medications.

States with Periodic In-Person Requirements

Alabama: After providing more than four telehealth visits for the same condition within 12 months, an in-person examination is required within that year. However, this can be satisfied by any collaborating provider in the practice—you don’t necessarily have to see the telehealth prescriber in person.

Georgia: Requires providers to attempt to schedule an in-person examination at least annually for ongoing telemedicine care. Initial evaluation can be done via telehealth if equivalent to in-person standards.

New Hampshire: A 2025 law allows telehealth prescribing to start without in-person contact, but requires at least one in-person follow-up examination every 12 months for continued treatment.

What ‘In-Person’ Really Means

If your state requires periodic in-person visits, understand that:

• This typically applies to ongoing treatment (not your initial evaluation)
• The in-person visit can often be with any qualified provider in your treatment network, not necessarily your telehealth prescriber
• The requirement is usually within a 12-month window, giving you flexibility in scheduling

Bottom line: In the vast majority of states, you can begin BED medication treatment entirely through telehealth. A handful of states ask for periodic in-person follow-ups for long-term care, but this rarely prevents initial access.

Prescription Monitoring Programs (PMPs): Do They Apply to BED Medications?

Prescription Drug Monitoring Programs are state databases that track controlled substance prescriptions. Most states require prescribers to check the PMP before writing prescriptions for opioids, stimulants, and similar medications.

For Topamax and Wellbutrin: These are not controlled substances, so mandatory PMP checks generally don’t apply. Your provider may still review your medication history as part of good clinical practice—to check for potential drug interactions or duplicate therapies—but they’re not legally required to perform a PMP lookup in most states.

This is actually good news for privacy-conscious patients. While PMP databases serve an important safety function, not every medication needs that level of tracking.

Who Can Prescribe BED Medications via Telehealth?

Medical Doctors (MDs) and Doctors of Osteopathy (DOs)

Physicians can prescribe these medications in all 50 states via telehealth, subject to their state’s telemedicine regulations.

Nurse Practitioners (NPs) and Physician Assistants (PAs)

This is where it gets more interesting—and has changed significantly in recent years.

Full Practice Authority States (34 states + DC as of 2025): In these states, Nurse Practitioners can practice independently, including prescribing medications without physician oversight. Recent additions include:

• Michigan (2025)
• Wisconsin (August 2025)
• Louisiana and Kansas (2023–2024)

In these states, an NP can evaluate you for BED and prescribe topiramate or bupropion completely independently via telehealth.

Collaborative/Supervisory States: In states like Texas, Florida, Georgia, and Alabama, NPs and PAs must work under a collaborative agreement or supervision by a physician. They can still prescribe these non-controlled medications for BED, but there’s a supervising physician relationship in the background.

From a patient perspective, this rarely affects your care. You’ll see the NP or PA for your appointments, and they’ll prescribe under their collaborative agreement. Both provider names may appear on documentation, but the treatment experience is essentially the same.

Restricted Practice States: Very few states significantly restrict NP/PA prescribing of non-controlled medications. Those restrictions usually apply to controlled substances, not medications like we’re discussing.

What this means for you: Whether you see an MD, DO, NP, or PA through a telehealth platform like Klarity Health, you can receive appropriate BED medication prescriptions. The provider type matters less than their experience with eating disorders and their ability to provide comprehensive, ongoing care.

The Telehealth Evaluation Process: What to Expect

Initial Assessment

A legitimate telehealth evaluation for BED medication should be thorough—typically 30 minutes or longer for an initial visit. Your provider will:

Assess BED criteria: Expect detailed questions about:

• Frequency and pattern of binge episodes
• Feelings of loss of control during eating
• Eating behaviors (eating rapidly, eating when not hungry, eating until uncomfortable)
• Emotional distress related to binge eating
• Absence of regular compensatory behaviors (purging, excessive exercise)

Review medical history: Including:

• Other mental health conditions (depression, anxiety, trauma history)
• Medical conditions that might affect treatment choices
• Current medications and supplements
• Previous eating disorder treatment
• Family history of eating disorders or mental health conditions

Screen for safety concerns:

• Seizure history or risk factors
• Pregnancy status and plans
• History of other eating disorders (particularly important for bupropion)
• Suicidal ideation (especially if considering bupropion)
• Substance use patterns

Discuss treatment options: A quality provider will explain:

• Why they’re recommending a particular medication
• How it works (and that it’s off-label use)
• Expected timeline for benefits
• Potential side effects
• Why medication should be combined with therapy/counseling
• Alternative approaches

Documentation and Consent

Your provider will document that you meet DSM-5 criteria for Binge Eating Disorder and that an appropriate telehealth evaluation was conducted. You’ll sign:

• Telehealth consent: Acknowledging the nature of virtual care and its limitations
• Informed consent for medication: Specifically for off-label use if applicable
• Privacy acknowledgment: Confirming you understand how your health information is protected

Many providers use standardized questionnaires like the Binge Eating Scale (BES) or Eating Disorder Examination Questionnaire (EDE-Q). These become part of your medical record and help track progress over time.

Prescription and Pharmacy Coordination

Once the evaluation is complete and medication is deemed appropriate, your provider will:

• Send an electronic prescription to your pharmacy of choice (required in most states)
• Provide clear instructions on dosing and titration
• Schedule follow-up appointments
• Give you contact information for questions or concerns

Red flag: Be cautious of any service that ships medication directly without using a licensed pharmacy. Legitimate telehealth providers send prescriptions to established pharmacies, ensuring you receive FDA-approved medications.

Who Should NOT Get BED Medication via Telehealth?

While telehealth expands access, it’s not appropriate for everyone. You may need in-person evaluation if:

Medical Contraindications

• History of anorexia or bulimia with purging: Bupropion is contraindicated due to severe seizure risk
• Seizure disorder or epilepsy: Both medications discussed require careful evaluation
• Pregnancy or planning pregnancy: Topiramate carries significant fetal risk; in-person monitoring is typically recommended
• Severe medical instability: Uncontrolled diabetes, heart conditions, or other serious health issues may require in-person assessment

Clinical Complexity

• Multiple untreated mental health conditions: If you’re struggling with severe depression, active suicidal ideation, psychosis, or other complex psychiatric issues, you likely need comprehensive in-person mental health care
• Active substance use disorder: Particularly if involving alcohol (contraindication for bupropion)
• Need for controlled medications: If evaluation suggests Vyvanse (the FDA-approved BED medication) might be most appropriate, you’ll likely need in-person care
• Recent eating disorder treatment: If you’ve recently been in intensive treatment for another eating disorder, your provider may want in-person coordination with that treatment team

Severe BED Presentations

• Medical complications: If binge eating has caused urgent health issues requiring close monitoring
• Need for intensive treatment: Sometimes BED requires intensive outpatient programs, partial hospitalization, or residential treatment—levels of care not provided via standard telehealth

A responsible telehealth provider will recognize when you need a higher level of care and make appropriate referrals. This is actually a sign of quality—they’re putting your safety first rather than trying to fit every patient into a telehealth model.

Off-Label Prescribing: What You Should Know

You might wonder: ‘If these medications aren’t FDA-approved specifically for BED, is it safe to take them?’

Off-label prescribing is legal, common, and often represents standard medical practice. In fact, an estimated 20% of all prescriptions written in the U.S. are for off-label uses.

Why These Medications Are Used Off-Label for BED

Topiramate: Multiple clinical trials have shown effectiveness in reducing binge frequency, binge days, and body weight in BED patients. While not FDA-approved for BED, it’s recommended in clinical practice guidelines as an option.

Bupropion: Research demonstrates that it can reduce binge eating episodes, particularly in patients with co-occurring depression. Its mechanism on dopamine and norepinephrine systems appears relevant to impulse control aspects of BED.

Your Provider’s Responsibility

When prescribing off-label, your provider should:

• Explain that it’s an off-label use
• Describe the evidence supporting this use
• Discuss FDA-approved alternatives (in this case, Vyvanse, though it has different access considerations)
• Document your informed consent
• Monitor your response and adjust treatment as needed

Your Rights as a Patient

You have the right to:

• Ask why a particular medication is being recommended
• Request information about the research supporting its use for BED
• Discuss other treatment options
• Decline medication and pursue therapy-only approaches
• Seek a second opinion

Reputable telehealth platforms are transparent about off-label use. If a provider seems evasive or dismissive when you ask about why they’re recommending a particular medication, that’s a red flag.

Ensuring Quality and Safety in Telehealth BED Treatment

The rapid expansion of telehealth during COVID-19 brought incredible access—but also some problematic actors. High-profile cases like the 2024 indictment of executives from a telehealth ADHD startup for unsafe prescribing practices have heightened regulatory scrutiny.

This is actually good news for patients seeking legitimate care. The increased attention has led to better standards and more accountability.

Signs of Quality Telehealth Care

Thorough evaluation process:

• Initial appointments of 30+ minutes
• Detailed medical and psychiatric history
• Discussion of multiple treatment options
• No pressure to accept a prescription

Licensed, credentialed providers:

• Clear information about provider credentials
• Verification that provider is licensed in your state
• Ability to verify license through state medical board

Comprehensive follow-up:

• Scheduled follow-up appointments (typically 2 weeks, then monthly initially)
• Clear protocol for reaching provider with concerns
• Medication monitoring for side effects
• Adjustment of treatment based on response

Transparent pricing:

• Clear costs upfront
• Information about insurance acceptance
• No hidden fees or pressure to prepay for multiple months

Coordination with other care:

• Recommendations for therapy/counseling
• Willingness to coordinate with your other providers
• Referrals when appropriate

Red Flags to Watch For

• Prescription guaranteed before evaluation: No legitimate provider can promise a prescription without first assessing you
• Minimal evaluation: If you’re prescribed medication after a 5-minute questionnaire, that’s insufficient
• Prescribing multiple new medications simultaneously: Usually unsafe; responsible providers start one medication at a time
• Selling medication directly: Prescriptions should go through licensed pharmacies
• Resistance to questions: Quality providers welcome your questions and concerns
• No mention of therapy: Medication alone is rarely optimal for BED; good providers discuss comprehensive treatment

How Klarity Health Ensures Quality Care

At Klarity Health, we’ve built our platform with these quality principles in mind:

Comprehensive evaluations: Our providers take time to understand your complete health picture, typically spending 30–45 minutes on initial BED assessments.

Licensed, experienced providers: Every provider is licensed in your state and has experience treating eating disorders. You can verify credentials and see provider backgrounds before your appointment.

Transparent pricing: We clearly display costs for visits and accept both insurance and self-pay options, so there are no surprises.

Ongoing care coordination: After your initial visit, we schedule regular follow-ups to monitor your response, adjust medications as needed, and ensure you’re also accessing therapy and other supportive care.

Available when you need us: With flexible scheduling including evenings and weekends, you can get care that fits your life—appointments are often available within 24–48 hours.

The Treatment Journey: What to Expect Month by Month

Month 1: Starting Treatment

Week 1–2: Initial evaluation and prescription. If starting topiramate, you’ll likely begin with a low dose (25mg) to minimize side effects. Bupropion typically starts at 150mg daily.

Week 2–3: First follow-up appointment. Your provider checks for side effects, early response, and tolerability. Topiramate dose may be increased gradually.

Week 4: Many patients begin noticing some reduction in binge urges, though full effects take longer.

Months 2–3: Adjustment Phase

• Regular (often biweekly) check-ins to monitor progress
• Gradual dose adjustments based on response and tolerability
• Discussion of therapy progress and other treatment components
• Side effect management

Months 3–6: Stabilization

• If medication is helping, symptoms should be improving significantly
• Follow-ups may space to monthly
• Focus shifts to sustaining gains and building recovery skills
• Ongoing coordination with therapy

Long-term (6+ months)

• Periodic check-ins to maintain treatment
• Reassessment of whether medication continues to be beneficial
• Discussion of duration of medication treatment
• Support for lifestyle changes and relapse prevention

Important: Medication response varies widely. Some people experience significant benefit, while others find limited help from medication and do better with therapy-focused approaches. Your provider should reassess regularly and adjust the plan based on your individual response.

Cost Considerations and Insurance Coverage

Insurance Coverage

Most insurance plans cover telehealth visits for mental health and eating disorder treatment at the same rate as in-person visits. This includes:

• Evaluation appointments
• Follow-up medication management visits
• Therapy sessions (if provided through the same platform)

However, medication coverage varies:

• Topiramate is usually well-covered as a generic medication
• Bupropion (generic Wellbutrin) is typically covered with minimal copay
• Some plans may require prior authorization or step therapy

Self-Pay Options

For those without insurance or preferring to pay out-of-pocket:

Telehealth visits are often more affordable than in-person appointments:

• Initial evaluations: typically $150–300
• Follow-up visits: often $75–150

Medications (generic, without insurance):

• Topiramate: usually $10–50/month
• Bupropion: typically $10–40/month

Klarity Health accepts both insurance and self-pay, with transparent pricing displayed before you book. Many patients find that even paying out-of-pocket for telehealth is more affordable and convenient than traditional in-person care when you factor in time off work, transportation, and other logistics.

Combining Medication with Other BED Treatments

While this guide focuses on medication access, it’s crucial to understand that medication works best as part of comprehensive treatment.

Evidence-Based Therapies for BED

Cognitive Behavioral Therapy (CBT): The most researched therapy for BED, CBT helps you:

• Identify triggers for binge eating
• Develop coping strategies
• Challenge unhelpful thoughts about food and body
• Establish regular eating patterns

Dialectical Behavior Therapy (DBT): Particularly helpful for emotional regulation:

• Mindfulness skills
• Distress tolerance
• Emotion regulation
• Interpersonal effectiveness

Interpersonal Psychotherapy (IPT): Focuses on relationship patterns and life transitions that may contribute to binge eating.

Nutritional Counseling

Working with a registered dietitian who specializes in eating disorders can help:

• Rebuild normal hunger/fullness cues
• Reduce food rules and restrictions that trigger binges
• Develop flexible, sustainable eating patterns
• Address nutritional deficiencies

Support Groups

Many people benefit from peer support through:

• Eating Disorders Anonymous
• Overeaters Anonymous
• NEDA support groups
• Online communities

Quality telehealth platforms often integrate these services. Ask your provider about access to therapy, nutrition counseling, and support resources in addition to medication management.

Recent Developments and What’s Coming (2025–2026)

Federal Regulatory Updates

The DEA has extended COVID-era telehealth flexibilities for controlled substance prescribing through December 31, 2026. While this primarily affects controlled medications (not the BED treatments discussed here), it reflects continued federal support for telehealth access.

A permanent DEA rule on telehealth controlled substance prescribing is expected by end of 2026. This may eventually affect access to medications like Vyvanse for BED, but the specifics remain uncertain.

State-Level Changes

Expanding NP independence: More states continue to grant full practice authority to Nurse Practitioners. Wisconsin and Michigan joined this group in 2025, improving access to prescribers in those states.

Clarifying telehealth standards: States like New Hampshire, Delaware, and California have refined their telehealth laws in 2024–2025, generally maintaining or expanding access while adding safety guardrails.

Increased enforcement: Both federal and state regulators are more actively monitoring telehealth prescribing practices. This means better protection for patients from questionable providers, though it may make some legitimate services more cautious.

What This Means for Patients

The telehealth landscape for BED treatment remains stable and accessible through at least the end of 2026, with continued strong support for non-controlled medication prescribing. If anything, the trend is toward:

• More states allowing NP independent practice (expanding provider availability)
• Clearer, more permanent telehealth regulations (reducing uncertainty)
• Better enforcement against bad actors (improving safety)

For patients seeking legitimate care through quality platforms, access continues to improve.

Taking the First Step: How to Get Started

If you’re ready to explore telehealth treatment for Binge Eating Disorder:

1. Prepare for Your Evaluation

Before your first appointment:

• Track your binge eating episodes (frequency, triggers, feelings)
• List current medications and supplements
• Note any previous eating disorder treatment
• Identify questions you want to ask
• Have insurance information ready if using insurance

2. Choose a Reputable Provider

Look for:

• Licensed providers with eating disorder experience
• Transparent pricing and policies
• Comprehensive evaluation process
• Good reviews from other patients
• Clear follow-up protocols

3. Be Honest During Evaluation

Your provider can only help with complete information. Share openly about:

• The full extent of your binge eating
• Co-occurring mental health symptoms
• Substance use
• Medical history
• Previous treatment experiences

4. Ask Questions

Don’t hesitate to ask:

• Why is this medication recommended for me?
• What are the risks and benefits?
• What side effects should I watch for?
• How long until I might see benefits?
• What if the medication doesn’t help?
• What other treatments should I pursue simultaneously?

5. Commit to Follow-Up

Medication requires monitoring:

• Attend all scheduled follow-up appointments
• Report side effects promptly
• Be honest about whether treatment is helping
• Stay engaged with therapy and other supports

Your Path Forward: Hope and Help Are Available

Binge Eating Disorder is a serious condition that affects every aspect of life—physical health, emotional well-being, relationships, and self-esteem. But it’s also highly treatable, especially when you access the right combination of supports.

Telehealth has removed many of the traditional barriers to getting help:

• No need to find a local specialist (often difficult, especially in rural areas)
• Faster access to appointments
• More flexible scheduling
• Often more affordable
• Privacy and comfort of receiving care from home

The medications we’ve discussed—topiramate and bupropion—are legally and safely available through telehealth across the United States. With minimal federal restrictions on non-controlled medications and most states maintaining flexible telehealth policies, you can access evidence-based treatment from licensed providers without navigating the complexity of in-person specialty care.

But remember: medication is a tool, not a complete solution. The most effective BED treatment combines:

• Medication (when appropriate)
• Evidence-based therapy
• Nutritional counseling
• Support systems
• Lifestyle changes
• Self-compassion and patience with the recovery process

Ready to Get Started?

Klarity Health makes it easy to access comprehensive BED treatment through our telehealth platform. Our experienced providers offer:

• Same-day or next-day appointments in most cases
• Thorough evaluations by providers who specialize in eating disorders
• Transparent pricing with both insurance and self-pay options accepted
• Ongoing medication management with regular follow-ups
• Coordination with therapy and other treatments you need
• Available across multiple states with licensed providers where you live

We understand that reaching out for help can feel overwhelming. That’s why we’ve designed our platform to be straightforward, supportive, and focused on your individual needs.

You don’t have to struggle with binge eating alone. Expert help is available, accessible, and closer than you think.

Take the first step today. Visit Klarity Health to schedule your confidential evaluation and start your path to recovery. You deserve support, effective treatment, and the freedom that comes with healing your relationship with food.

Research Currency Statement

Verified as of: January 4, 2026

This guide is based on the most current federal and state regulations governing telehealth prescribing as of early 2026:

• Federal DEA Rules: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). Non-controlled medications like topiramate and bupropion were never subject to Ryan Haight Act restrictions and remain fully available via telehealth.

• State Regulations: Information verified across 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, SC) with latest updates as of late 2025. State medical board and legislative sources were checked for accuracy.

• Source Recency: Over 80% of sources are from 2025 or updated to 2025. Older sources (2024) were included only when confirmed accurate by newer references.

• Pending Updates: Alabama and South Carolina NP scope-of-practice legislation was proposed in 2025 but final status remains to be confirmed. DEA’s permanent telehealth prescribing rule is expected by end of 2026. Readers should verify any temporary state waivers for extensions beyond noted expiration dates.

Key Citations

1. U.S. Department of Health and Human Services. (2026, January). ‘DEA Extends Telemedicine Prescribing Flexibilities Through December 2026.’ Available at: www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Richter & Hampton LLP. (2025, August). ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Available at: www.sheppardhealthlaw.com/2025/08/articles/telehealth/

3. Center for Connected Health Policy. (2025, November-December). ‘State Telehealth Laws and Reimbursement Policies: Online Prescribing.’ Available at: www.cchpca.org/topic/online-prescribing/

4. National Law Review. (2025). ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Available at: natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era

5. Health Jobs Nationwide. (2025). ‘State-by-State Guide: Expanding Roles for PAs and NPs – Updated 2025.’ Available at: blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

Note: All regulatory information is subject to change. Patients should verify current rules in their specific state and consult with licensed providers for individual medical advice.

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12